It’s the doctor’s duty to use the placebo effect

Margaret McCartney wrote about the placebo effect on this blog earlier in the week, in the context of the Commons Science committee recommending that the NHS should not pay for homeopathy.

Coincidentally The Lancet has a fascinating long review of placebos, looking at the clinical evidence and ethical considerations.

The authors, led by Damien Finniss of the University of Sydney, point out that placebo effects are “genuine psychobiological events” which can be produced in both laboratory and clinical settings.

A key conclusion is that there are many different placebo effects, depending on circumstances.

Most research into the biological mechanisms of placebo effects is concerned with pain relief. Sometimes these are mediated by “endogenous opioids” released by the brain, sometimes by other mechanisms.

There are other placebo effects across the body, including changes in heart, lung and hormone function.

The most important message of the paper is: “You don’t need to give a placebo [an inert pill or dummy procedure] to create a placebo effect. Placebo effects are part of routine medical practice and are potentially active every time a patient enters a therapeutic context.”

Or, as Margaret put it, “The placebo effect is not a nuisance. It is our best friend, and it needn’t be deceptive.”

Every doctor should work to maximise the placebo effect, to make his or her treatment of the patient as effective as possible.

Health and science blog




This blog, part of the FT's health series, is a forum for readers interested in the science, policy, management, technology, business and delivery of healthcare.

This blog is no longer active but it remains open as an archive.
Follow on twitter

About our regular bloggers

Margaret McCartney is a Glasgow-based GP and FT Weekend columnist. She started writing for the Life and Arts section in 2005 and moved to the magazine in 2008. She also has her own blog: www.margaretmccartney.com/blog

Clive Cookson has been a science journalist for the whole of his working life. He joined the FT in 1987. Clive, the FT's science editor, picks out the research that everyone should know about. He also discusses key policy issues, from R&D funding to science education.

Andrew Jack is pharmaceuticals correspondent, covering the industry and public health issues. He has been a journalist with the FT for 19 years, based in London, Paris and Moscow

The Health blog: a guide

Comment: To comment, please register with FT.com, which you can do for free here. Please also read our comments policy here.
Contact: You can write to Ursula Milton, the blog's editor, using this email format: firstname.surname@ft.com
Time: UK time is shown on posts.
Follow: Links to the blog's Twitter and RSS feeds are at the top of the page. You can also read the Health blog on your mobile device, by going to www.ft.com/healthblog
FT blogs: See the full range of the FT's blogs here.